A Phase IV Prospective Safety Surveillance Cohort Study Of ACAM2000 In Deploying Military Personnel.
Phase of Trial: Phase IV
Latest Information Update: 22 Feb 2016
At a glance
- Drugs ACAM 2000 (Primary) ; Smallpox vaccine
- Indications Smallpox
- Focus Adverse reactions
- Sponsors Sanofi; sanofi pasteur
- 18 Feb 2016 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 17 Mar 2015 Planned End Date changed from 1 Dec 2014 to 1 Dec 2015 as reported by ClinicalTrials.gov.
- 17 Mar 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.